Literature DB >> 1621680

Patients with a low income have reduced renal allograft survival.

R S Kalil1, K L Heim-Duthoy, B L Kasiske.   

Abstract

The impact of socioeconomic factors on long-term outcome after renal transplantation is unknown. We examined the effects of family income among 202 patients transplanted between 1976 and 1982 who had an allograft that functioned for at least 1 year. Compared with patients with an adequate income, recipients of medical assistance at the time of transplantation were more likely to return to dialysis after 1 year (16/45 [36%] v 26/157 [17%], P less than 0.01), or after 5 years of graft function (10/38 [26%] v 12/116 [10%], P less than 0.01). Patients who complied with fewer than 85% of visits during the first 2 years were also more likely to return to dialysis after 1 year (17/49 [35%] v 25/153 [16%], P less than 0.01), or after 5 years (8/31 [26%] v 14/123 [11%], P less than 0.05) than were more compliant patients. However, noncompliance was not different in patients with and without a low income (37/157 [24%] v 12/45 [27%], P greater than 0.05). The relative risk for returning to dialysis after 5 years was 2.4 (P less than 0.05) for low income and 3.0 (P less than 0.05) for less than 85% compliance using a Cox proportional hazards model. These effects were independent of prior transplantation, mismatches, pre-formed antibodies, delayed graft function, age, sex, diabetes, alcohol or drug abuse, education, race, distance from the transplant center, and living in an urban environment (relative risk = 2.5, P less than 0.05). Neither income nor compliance could be linked to death.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1621680     DOI: 10.1016/s0272-6386(12)80318-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

Review 1.  Disparities in kidney transplant outcomes: a review.

Authors:  Elisa J Gordon; Daniela P Ladner; Juan Carlos Caicedo; John Franklin
Journal:  Semin Nephrol       Date:  2010-01       Impact factor: 5.299

Review 2.  Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?

Authors:  Erika Nerini; Fulvio Bruno; Franco Citterio; Francesco P Schena
Journal:  J Nephrol       Date:  2016-02-17       Impact factor: 3.902

3.  Can focusing on self-care reduce disparities in kidney transplantation outcomes?

Authors:  Elisa J Gordon; Thomas Prohaska; Laura A Siminoff; Peter J Minich; Ashwini R Sehgal
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

4.  Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

Authors:  David J Taber; Kelly J Hunt; Cory E Fominaya; Elizabeth H Payne; Mulugeta Gebregziabher; Titte R Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

Review 5.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

6.  Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Kelly J Hunt; Titte Srinivas; Kenneth D Chavin; Prabhakar K Baliga; Leonard E Egede
Journal:  Kidney Int       Date:  2016-08-20       Impact factor: 10.612

7.  Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.

Authors:  David J Taber; Kevin Douglass; Titte Srinivas; John W McGillicuddy; Charles F Bratton; Kenneth D Chavin; Prabhakar K Baliga; Leonard E Egede
Journal:  Am J Nephrol       Date:  2014-06-25       Impact factor: 3.754

8.  Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage.

Authors:  R S Woodward; T F Page; R Soares; M A Schnitzler; K L Lentine; D C Brennan
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

9.  Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Aurora Posadas; Caitlin Schaffner; Leonard E Egede; Prabhakar K Baliga
Journal:  J Am Coll Clin Pharm       Date:  2018-06-21

10.  Distance from treatment facility and risk of death from cardiovascular and infectious causes in renal transplant patients.

Authors:  A R Soliman; A Fathy; M Elkhatib; M A Soliman; N Shaheen
Journal:  Indian J Nephrol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.